Abraxis Bioscience, LLC v. Lee

563 F. App'x 786
Court of Appeals for the Federal Circuit·Decided June 18, 2014·No. No. 2014-1330·Published

Opinion

ON MOTION

ORDER

PROST, Chief Judge.

The parties jointly move to remand to the district court in light of Novartis AG v. Lee, 740 F.3d 593 (Fed.Cir.2014).

Based on Novartis, the parties agree that the patent term adjustment at issue in this appeal should be 323 days. Thus, the parties seek a remand with instructions for the district court to vacate the portion of its judgment denying the patent term adjustment and further instructions to remand to the U.S. Patent and Trademark Office for the purpose of recalculating the patent term adjustment.

Accordingly,

It Is Ordered That:

(1) The motion is granted. The case is remanded for further proceedings consistent with this order.

(2) Each party shall bear its own costs.

Free access — add to your briefcase to read the full text and ask questions with AI

Abraxis Bioscience, LLC v. Lee, 563 F. App'x 786 (Fed. Cir. 2014).

563 F. App'x 786 (Abraxis Bioscience, LLC v. Lee) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Novartis Ag v. Focarino
740 F.3d 593 (Federal Circuit, 2014)